HAR1A and central nervous system cancer: Chen et al. (2020) demonstrated that lower HAR1A expression may result in a worse outcome for glioma patients (Waters et al., 2021). The expression level of lncRNA FAM181A-AS1 correlates with advanced tumor stage and survival of glioma (Jiang and Chen, 2020).